University of Minnesota Masonic Children’s Hospital pediatric rheumatologists have been named “Rising Stars” by Mpls.St.Paul Magazine in its Sept. 2015 edition of Twin Cities’ Top Doctors. Colleen Correll, MD, MPH, and Patricia Hobday, MD, were chosen for the honor by their peers in an annual survey of area doctors. The magazine’s list recognizes outstanding Twin Cities’ physicians who have been practicing for 10 years or less. Both physicians are past graduates of the University of Minnesota Pediatric Rheumatology Fellowship Program. Drs. Correll and Hobday are currently accepting new patients. For referrals, please call 888-KIDS-UMN (888-543-7866).
University of Minnesota Masonic Children’s Hospital is now enrolling selected pediatric rheumatology patients into 2 clinical studies. The first is an observational study to carefully monitor the pharmacokinetics, efficacy, and safety of abatacept when administered subcutaneously in children and adolescents with active polyarticular juvenile idiopathic arthritis (JIA). Abatacept works by inhibiting T-cell activation, thereby modulating the inflammatory cascade in JIA. The second is an open-label study to evaluate the pharmacokinetics, safety, tolerability, and long-term follow-up of tofacitinib in patients with JIA active in 5 or more joints. Tofacitinib is a Janus kinase inhibitor that reduces the production of inflammatory mediators in joint tissue. For more information, please contact our research study coordinator Leif Olson at 612-301-1554 or firstname.lastname@example.org.
University of Minnesota Medical School’s Division of Pediatric Rheumatology welcomes our newest Pediatric Rheumatology Fellow, Danielle Bullock, MD. Bullock is a graduate of Indiana University School of Medicine and recently completed her residency in pediatrics at University of Minnesota Medical School. The Pediatric Rheumatology Fellowship Program trains new specialists with the goal of advancing patient care, professional education, and research into arthritis and other pediatric rheumatic conditions. For information on the fellowship, please contact Program Director Bryce Binstadt, MD, PhD, at email@example.com.
Rheumatic diseases affect about 300,000 children in the United States. However, identifying the signs of arthritis and the types of diagnostic input needed can be challenging.Continue reading
A young girl’s path to diagnosis and treatment lasts 6 weeks. Under specialist care, her arthritis symptoms come under control. Three years later she continues to do well, with normal growth and development.Continue reading